Home - IAVI
We are a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. We take a full-circle approach to product development, from the grassroots level to the lab to legislative bodies. To translate scientific discoveries into affordable, globally accessible public health solutions. A world where all people have equitable access to innovative vaccines and therapeutics. HIV/AIDS remains one of the deadliest infectious diseases, with 1.3 million people acquiring HIV in 2022. Given the complexities of HIV, traditional approaches to vaccine development have so far failed to result in a vaccine that provides protection against HIV. However, a vaccine is still needed to bring a true end to the HIV pandemic. Source: UNAIDS IAVI scientists and our collaborators are developing next-generation HIV vaccines to address the challenges of HIV vaccine design. Together, we have pioneered promising new vaccination strategies an
The challenge HIV/AIDS remains one of the deadliest infectious diseases, with 1.4 million people acquiring HIV in 2024. Given the complexities of HIV, traditional approaches to vaccine development have so far failed to result in a preventive vaccine. However, a vaccine is still needed to bring a true end to the HIV pandemic. Source: UNAIDS Our solution IAVI scientists and our collaborators are developing next-generation HIV vaccines to address the challenges of HIV vaccine design. Together, we have pioneered promising new vaccination strategies and the discovery of broadly neutralizing…
related reading
- New HIV vaccine shows unprecedented success in preclinical study – lji.orglji.org
- Why we didn't get a malaria vaccine sooner - Works in Progress Magazineworksinprogress.co
- The golden age of vaccine development - Works in Progress Magazineworksinprogress.co
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Control of Viral Infections and Diseases - Medical Microbiology - NCBI Bookshelfncbi.nlm.nih.gov
- Interceptinterceptfund.com
- Hard Drugs | Lenacapavir: The miracle drug that could end AIDSharddrugs.worksinprogress.co
- JCI - Prototype pathogen approach for pandemic preparedness: world on firejci.org
- Progress Deferred: mRNA Vaccine Development Lessons | IFPifp.org
- mRNA vaccines for HIV trigger strong immune response in peoplenature.com
- radvacradvac.org
- PopVax develops RNA vaccines and cancer immunotherapies to save 1 million lives each yearpopvax.com